KORU Medical Systems Inc. (KRMD)
(Delayed Data from NSDQ)
$2.60 USD
-0.13 (-4.76%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $2.60 0.00 (0.00%) 5:26 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Income Statements
Fiscal Year end for KORU Medical Systems Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 29 | 28 | 23 | 24 | 23 |
Cost Of Goods | 12 | 13 | 10 | 9 | 8 |
Gross Profit | 17 | 15 | 14 | 15 | 15 |
Selling & Adminstrative & Depr. & Amort Expenses | 27 | 26 | 21 | 16 | 14 |
Income After Depreciation & Amortization | -10 | -11 | -7 | -1 | 1 |
Non-Operating Income | 1 | 0 | 1 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -10 | -11 | -6 | -1 | 1 |
Income Taxes | 4 | -2 | -2 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -14 | -9 | -5 | -1 | 1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -14 | -9 | -5 | -1 | 1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -9 | -10 | -7 | -1 | 1 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -10 | -11 | -7 | -1 | 1 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 45.60 | 45.00 | 44.39 | 41.93 | 39.06 |
Diluted EPS Before Non-Recurring Items | -0.13 | -0.16 | -0.07 | 0.02 | 0.01 |
Diluted Net EPS (GAAP) | -0.30 | -0.19 | -0.10 | -0.03 | 0.01 |
Fiscal Year end for KORU Medical Systems Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 8.43 | 8.20 | 7.19 | 7.00 |
Cost Of Goods | NA | 2.95 | 3.09 | 2.85 | 2.66 |
Gross Profit | NA | 5.48 | 5.10 | 4.33 | 4.34 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.67 | 7.07 | 6.53 | 6.13 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1.19 | -1.97 | -2.20 | -1.79 |
Non-Operating Income | NA | 0.20 | 0.03 | 0.18 | 0.12 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -0.99 | -1.94 | -2.02 | -1.67 |
Income Taxes | NA | 0.00 | 0.00 | 5.45 | -0.30 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -0.99 | -1.94 | -7.47 | -1.37 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -0.99 | -1.94 | -7.47 | -1.37 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 45.81 | 45.71 | 45.67 | 45.64 |
Diluted EPS Before Non-Recurring Items | NA | -0.02 | -0.02 | -0.02 | -0.03 |
Diluted Net EPS (GAAP) | NA | -0.02 | -0.04 | -0.17 | -0.03 |